Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transdermal scopolamine-induced psychosis.

A A Ziskind1

  • 1Cardiac Unit, Massachusetts General Hospital, Boston 02114.

Postgraduate Medicine
|September 1, 1988
PubMed
Summary

Transdermal scopolamine effectively prevents motion sickness with fewer central nervous system side effects. However, side effects can occur, especially in vulnerable populations, requiring careful diagnosis and management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessing the appropriateness of coronary revascularization: the University of Maryland Revascularization Appropriateness Score (RAS) and its comparison to RAND expert panel ratings and American College of Cardiology/American Heart Association guidelines with regard to assigned appropriateness rating and ability to predict outcome.

Clinical cardiology·1999
Same author

Pulmonary hypertension decreases the predictive accuracy of echocardiographic clues for cardiac tamponade.

Chest·1995
Same author

Radiographic contrast waste in cardiac catheterization laboratories.

The American journal of cardiology·1994
Same author

Pulmonary sequestration receiving arterial supply from the left circumflex coronary artery.

Chest·1994
Same author

Percutaneous pericardial biopsy as an adjunctive technique for the diagnosis of pericardial disease.

The American journal of cardiology·1994
Same author

Successful use of education and cost-based feedback strategies to reduce physician utilization of low-osmolality contrast agents in the cardiac catheterization laboratory.

The American journal of cardiology·1994

Area of Science:

  • Pharmacology
  • Neurology
  • Gastroenterology

Background:

  • Transdermal scopolamine (Transderm-Scop) is widely used for motion sickness prophylaxis.
  • It is associated with a lower incidence of central nervous system (CNS) side effects compared to oral scopolamine.

Observation:

  • CNS side effects, though uncommon, are more prevalent in the elderly, individuals with psychiatric conditions, and those using concurrent anticholinergic medications.
  • Diagnosis can be challenging due to the hidden delivery system, delayed symptom onset, prolonged effects, lack of peripheral signs, and negative toxicology screens.

Findings:

  • Transdermal scopolamine offers effective motion sickness prevention.
  • Potential CNS side effects necessitate vigilance, particularly in at-risk patient groups.

Implications:

  • Clinicians should consider potential anticholinergic side effects of transdermal scopolamine, especially in elderly or psychiatrically predisposed patients.
  • Diagnostic challenges require a high index of suspicion for accurate identification of adverse events.
  • Supportive care is the primary treatment, with physostigmine reserved for severe cases.

Related Experiment Videos